Alliance Boots to reduce wholesaling division headcount by 10%
This article was originally published in Scrip
Executive Summary
Market conditions for Alliance Boots' pharmaceutical wholesale division in the past 12 months have been the most difficult that it has seen, the company says in its preliminary financial results announcement for the year ended March 31st. It has embarked on a restructuring to produce operating cost savings of £55 million per annum by 2011-12, which includes a 10% reduction in headcount in the division.